Pular para conteúdo

Medicina neonatal

Manejo da hiperbilirrubinemia

Fototerapia

Randomised controlled trial of single phototherapy with reflecting curtains versus double phototherapy in term newborns with hyperbilirubinaemia. (abre nova janela)

Abd Hamid IJ, M Iyen MI, Ibrahim NR, Abd Majid N, Ramli N, Van Rostenberghe H.

Fonte‎: J Paediatr Child Health 2013;49(5):375-9.

Indexado‎: PubMed 23573836

DOI‎: 10.1111/jpc.12192

https://www.ncbi.nlm.nih.gov/pubmed/23573836 (abre nova janela)

Phototherapy to prevent severe neonatal hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. (abre nova janela)

Bhutani VK; Committee on Fetus and Newborn; American Academy of Pediatrics.

Fonte‎: Pediatrics 2011;128(4):e1046-52.

Indexado‎: PubMed 21949150

DOI‎: 10.1542/peds.2011-1494

https://www.ncbi.nlm.nih.gov/pubmed/21949150 (abre nova janela)

High-intensity phototherapy for the treatment of severe nonhaemolytic neonatal hyperbilirubinemia. (abre nova janela)

de Carvalho M, Mochdece CC, Sá CA, Moreira ME.

Fonte‎: Acta Paediatr 2011;100(4):620-3.

Indexado‎: PubMed 21251060

DOI‎: 10.1111/j.1651-2227.2011.02170.x

https://www.ncbi.nlm.nih.gov/pubmed/21251060 (abre nova janela)

Efficacy of phototherapy for neonatal jaundice is increased by the use of low-cost white reflecting curtains. (abre nova janela)

Djokomuljanto S, Quah BS, Surini Y, Noraida R, Ismail NZ, Hansen TW, Van Rostenberghe H.

Fonte‎: Arch Dis Child Fetal Neonatal Ed 2006;91(6):F439-42.

Indexado‎: PubMed 16877479

DOI‎: 10.1136/adc.2006.095687

https://www.ncbi.nlm.nih.gov/pubmed/16877479 (abre nova janela)

Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia. (abre nova janela)

Gholitabar M, McGuire H, Rennie J, Manning D, Lai R.

Fonte‎: Cochrane Database Syst Rev 2012;(12):CD009017.

Indexado‎: PubMed 23235669

DOI‎: 10.1002/14651858.CD009017.pub2

https://www.ncbi.nlm.nih.gov/pubmed/23235669 (abre nova janela)

Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. (abre nova janela)

Kumar P, Chawla D, Deorari A.

Fonte‎: Cochrane Database Syst Rev 2011;(12):CD007969.

Indexado‎: PubMed 22161417

DOI‎: 10.1002/14651858.CD007969.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22161417 (abre nova janela)

Efficacy of phototherapy devices and outcomes among extremely low birth weight infants: multi-center observational study. (abre nova janela)

Morris BH, Tyson JE, Stevenson DK, Oh W, Phelps DL, O'Shea TM, McDavid GE, Van Meurs KP, Vohr BR, Grisby C, Yao Q, Kandefer S, Wallace D, Higgins RD.

Fonte‎: J Perinatol 2013;33(2):126-33.

Indexado‎: PubMed 22499082

DOI‎: 10.1038/jp.2012.39

https://www.ncbi.nlm.nih.gov/pubmed/22499082 (abre nova janela)

Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. (abre nova janela)

Okwundu CI, Okoromah CA, Shah PS.

Fonte‎: Cochrane Database Syst Rev 2012;(1):CD007966.

Indexado‎: PubMed 22258977

DOI‎: 10.1002/14651858.CD007966.pub2

https://www.ncbi.nlm.nih.gov/pubmed/22258977 (abre nova janela)

The effect of clofibrate with phototherapy in late pre-term newborns with non-hemolytic jaundice. (abre nova janela)

Sakha SH, Gharehbaghi MM, Rahbani ME.

Fonte‎: Indian J Med Sci 2009;63(5):174-9.

Indexado‎: PubMed 19584487

DOI‎: 10.4103/0019-5359.53162

https://www.ncbi.nlm.nih.gov/pubmed/19584487 (abre nova janela)

A randomized trial of phototherapy with filtered sunlight in African neonates. (abre nova janela)

Slusher TM, Olusanya BO, Vreman HJ, Brearley AM, Vaucher YE, Lund TC, Wong RJ, Emokpae AA, Stevenson DK.

Fonte‎: N Engl J Med 2015;373(12):1115-24.

Indexado‎: PubMed 26376136

DOI‎: 10.1056/NEJMoa1501074

https://www.ncbi.nlm.nih.gov/pubmed/26376136 (abre nova janela)

Dose-response relationship of phototherapy for hyperbilirubinemia. (abre nova janela)

Vandborg PK, Hansen BM, Greisen G, Ebbesen F.

Fonte‎: Pediatrics 2012;130(2):e352-7.

Indexado‎: PubMed 22802603

DOI‎: 10.1542/peds.2011-3235

https://www.ncbi.nlm.nih.gov/pubmed/22802603 (abre nova janela)

Imunoglobulina intravenosa 

High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. (abre nova janela)

Alpay F, Sarici SU, Okutan V, Erdem G, Ozcan O, Gökçay E.

Fonte‎: Acta Paediatr 1999;88(2):216-9.

Indexado‎: PubMed 10102158

https://www.ncbi.nlm.nih.gov/pubmed/10102158 (abre nova janela)

High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. (abre nova janela)

Dağoğlu T, Ovali F, Samanci N, Bengisu E.

Fonte‎: J Int Med Res 1995;23(4):264-71.

Indexado‎: PubMed 7589769

DOI‎: 10.1177/030006059502300406

https://www.ncbi.nlm.nih.gov/pubmed/7589769 (abre nova janela)

Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and ABO incompatibility. (abre nova janela)

Huizing K, Røislien J, Hansen T.

Fonte‎: Acta Paediatr 2008;97(10):1362-5.

Indexado‎: PubMed 18616629

DOI‎: 10.1111/j.1651-2227.2008.00915.x

https://www.ncbi.nlm.nih.gov/pubmed/18616629 (abre nova janela)

Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. (abre nova janela)

Miqdad AM, Abdelbasit OB, Shaheed MM, Seidahmed MZ, Abomelha AM, Arcala OP.

Fonte‎: J Matern Fetal Neonatal Med 2004;16(3):163-6.

Indexado‎: PubMed 15590442

DOI‎: 10.1080/14767050400009873

https://www.ncbi.nlm.nih.gov/pubmed/15590442 (abre nova janela)

Mesoporfirina de estanho

Clinical trial of tin mesoporphyrin to prevent neonatal hyperbilirubinemia. (abre nova janela)

Bhutani VK, Poland R, Meloy LD, Hegyi T, Fanaroff AA, Maisels MJ.

Fonte‎: J Perinatol 2016;36(7):533-9.

Indexado‎: PubMed 26938918

DOI‎: 10.1038/jp.2016.22

https://www.ncbi.nlm.nih.gov/pubmed/26938918 (abre nova janela)

Tin-mesoporphyrin in the treatment of severe hyperbilirubinemia in a very-low-birth-weight infant. (abre nova janela)

Reddy P, Najundaswamy S, Mehta R, Petrova A, Hegyi T.

Fonte‎: J Perinatol 2003;23(6):507-8.

Indexado‎: PubMed 13679941

DOI‎: 10.1038/sj.jp.7210943

https://www.ncbi.nlm.nih.gov/pubmed/13679941 (abre nova janela)

Outros agentes

Effect of ursodeoxycholic acid on indirect hyperbilirubinemia in neonates treated with phototherapy. (abre nova janela)

Honar N, Ghashghaei Saadi E, Saki F, Pishva N, Shakibazad N, Hosseini Teshnizi S.

Fonte‎: J Pediatr Gastroenterol Nutr 2016;62(1):97-100.

Indexado‎: PubMed 26020375

DOI‎: 10.1097/MPG.0000000000000874

https://www.ncbi.nlm.nih.gov/pubmed/26020375 (abre nova janela)

Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications. (abre nova janela)

Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watchko JF.

Fonte‎: Pediatrics 2009;124(4):1193-8.

Indexado‎: PubMed 19786452

DOI‎: 10.1542/peds.2009-0329

https://www.ncbi.nlm.nih.gov/pubmed/19786452 (abre nova janela)

A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia. (abre nova janela)

Mehta S, Kumar P, Narang A.

Fonte‎: J Pediatr 2005;147(6):781-5.

Indexado‎: PubMed 16356431

DOI‎: 10.1016/j.jpeds.2005.07.026

https://www.ncbi.nlm.nih.gov/pubmed/16356431 (abre nova janela)

Treatment of clofibrate in jaundiced low birth weight neonates. [English, Turkish abstract] (abre nova janela)

Mohammadzadeh A, Farhat AS, Amiri R, Esmaely H, Bagheri S.

Fonte‎: UHOD-Uluslar Hematol Onkol De (Int J Hematol Oncol) 2009;19(2):100-5.

Indexado‎: EMBASE 2009472903

http://www.uhod.org/summary_en.php3?id=359 (abre nova janela)

Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial). (abre nova janela)

Zahedpasha Y, Ahmadpour-Kacho M, Hajiahmadi M, Naderi S, Kamali AA.

Fonte‎: Southeast Asian J Trop Med Public Health 2008;39(3):557-61.

Indexado‎: PubMed 18564698

https://www.ncbi.nlm.nih.gov/pubmed/18564698 (abre nova janela)